New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2013
10:55 EDTKITD, KITD, CDTI, CDTI, ICUI, ICUI, STMP, STMP, XPL, XPL, XRS, XRS, YOD, YOD, COA, COA, HZNP, HZNP, ICPW, ICPW, BDSI, BDSIRoth Capital to host a conference
25th Annual Roth Conference is being held in Dana Point, California on March 17-20 with webcasted company presentations to begin on March 18 at 11 am; not all company presentations may be webcasted. Webcast Link
News For KITD;ICPW;HZNP;COA;YOD;XRS;XPL;STMP;ICUI;CDTI;BDSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
10:23 EDTXRSTAL Education downgraded to Hold from Buy at T.H. Capital
Subscribe for More Information
07:45 EDTHZNPHorizon Pharma to host conference call
Subscribe for More Information
07:04 EDTHZNPHorizon Pharma acquires U.S. rights to PENNSAID 2% for $45M
Subscribe for More Information
October 13, 2014
17:06 EDTHZNPHorizon Pharma: Actimmune net sales potential $500M with FDA approval for FA
Subscribe for More Information
05:31 EDTHZNPHorizon Pharma to host analyst day
Analyst Day to be held in King of Prussia, PA on October 13 at 5 pm. Webcast Link
October 10, 2014
10:01 EDTBDSIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:02 EDTBDSIBioDelivery Sciences downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information
October 9, 2014
15:31 EDTHZNPHorizon Pharma's Actimmune Phase 2 results provide more growth, says Avondale
Avondale said Horizon Pharma's Actimmune Phase 2 results were strong and support incremental annual market opportunity of approximately $300K per year. The firm views the results as another potential growth driver and its Outperform rating and $22 price target.
13:40 EDTHZNPHorizon Pharma presents ACTIMMUNE Phase 2 data
Subscribe for More Information
10:41 EDTXRSHigh option volume stocks
Subscribe for More Information
October 6, 2014
09:39 EDTBDSIUSPTO institutes review brought by MonoSol against claims in BioDelivery patent
Subscribe for More Information
06:31 EDTXRSPrime Capital reports 5.17% passive stake in TAL Education
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use